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Juxin Yina, Yuanjie Suoa, Zheyu Zou a, Jingjing Suna, Shan Zhanga, Beng Wangbf, Yawei Xuc, Diane Darlandd※, Julia Xiaojun
Zhaoe※, Ying Mu a※
Rapid, efficient and accurate nucleic acid molecule detection is important in the screening of diseases and pathogens, yet
remains a limiting factor at point of care (POC) treatment. Microfluidic systems are characterized by fast, integrated,
miniaturized features which provide an effective platform for qualitative and quantitative detection of nucleic acid
molecules. The nucleic acid detection process mainly includes sample preparation and target molecule amplification. Given
the advancements in theoretical research and technological innovations to date, nucleic acid extraction and amplification
integrated with microfluidic systems has advanced rapidly. The primary goal of this review is to outline current approaches
used for nucleic acid detection in the context of microfluidic systems. The secondary goal is to identify new approaches that
will help shape future trends at the intersection of nucleic acid detection and microfluidics, particularly with regard to
increasing disease and pathogen detection for improved diagnosis and treatment.

Introduction
Molecular diagnosis is a technique that uses molecular biology
methods to detect changes in the structure or level of
expression of patient-derived genetic material. This technique
involves nucleic acid amplification testing (NAAT) technology.
With the high demand for rapid detection tools for diseases and
pathogens in the fields of medicine and food safety, the focus
has been directed towards molecular diagnostic approaches for
Point of Care (POC). POC is an approach that involves analyzing
samples at the site of sample collection, thereby reducing the
time required for diagnosis and eliminating (or reducing) the
need to transfer specimens to offsite testing laboratories 1-5.
The rapid turnaround for POC diagnosis usually does not require
professional personnel, such as clinical examiners, for sample
processing and analysis. Compared with traditional laboratory
detection methods, POC primarily achieves portable in-situ
detection partially completed by technical staff which
streamlines operational procedures, integrates detection
devices, and reduces detection costs 6-8. The microfluidic chip
a.
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technology, also known as the micro Total Analysis System
(µTAS) was first proposed by Manz and colleagues in the 1990s
9. With more than twenty years of development, it has become
an independent area of biochemical analysis. The microfluidic
chip has features such as rapid and efficient analysis, low
consumption, and miniaturization. Moreover, it has the ability
to perform nucleic acid extraction and detection on a single
chip, thereby providing an excellent platform for POC 10, 11.
Figure 1 highlights the conceptual intersection of technical
improvements for nucleic acid isolation and amplification with
the microfluidics platform. Improvement at any of these critical
technical points confers additive advancements that directly
contribute to improved POC and increased treatment efficiency
(Fig. 1).
To provide real-time diagnosis of diseases and early screening
for diseases 12-14, it is important to develop techniques that
allow for accurate and rapid detection of nucleic acids, including
deoxyribonucleic acid (DNA) and ribonucleic acid (RNA), which
may reveal the contamination of pathogens in food and the
environment as well as the emergence of tumor markers using
tissue scrapes and biopsies. Indeed, the discovery of circulating
nucleic acids has allowed for fast, accurate, and cost-effective
detection of nucleic acids, thereby playing an increasingly
important role in the early diagnosis of disease 15-17. Traditional
nucleic acid detection methods have several challenges,
including lengthy preparation and analysis time, vulnerability to
contamination, sensitivity limitations, and complex procedures
and operation. Collectively, these challenges limit the
effectiveness of these methods in POC. Integration of
microfluidic technology with nucleic acid extraction helps to
address previous technical and analytical limitations associated
with nucleic acid detection.
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The development of nucleic acid detection technology based on
the microfluidic chip has greatly improved the diagnostic
efficiency and accuracy of various diseases 18, 19. NAAT based on
the microfluidic chip has the advantages of being highly
sensitive and specific, while still providing a user-friendly
workflow with good qualitative and quantitative detection
potential 20-22. A specific example of this is the Integrated nucleic
acid extraction, amplification, and Detection (INEAD) system
developed by combining microfluidic applications in POC and
clinical diagnosis. The chip can be used for sample preparation,
nucleic acid signal amplification, and quantification of results on
a single device, which actualizes the goal of "sample-in-answer
out". The entire procedure is performed in a closed
environment, which reduces the burden on the operator and
addresses the need for rapid detection without time and
location constraints.
In this review, we will focus on current methods for extraction
of nucleic acids in microfluidic systems and advanced methods
for nucleic acid amplification implemented in microfluidic
systems. Furthermore, we will introduce current technologies
and approaches integrating the INEAD system and provide an
outlook for future technological approaches.
2. Current methods in nucleic acid isolation and
purification
Nucleic acid extraction is the "first step" in molecular
diagnostics and nucleic acid detection for research applications.
The extraction of nucleic acids mainly refers to the separation
of nucleic acids from biological macromolecules such as
proteins, polysaccharides, and fats. The following target goals
are associated with nucleic acid extraction: to ensure the
integrity of the primary structure of nucleic acid molecules is
preserved; to exclude other molecular contaminants; and to
optimize yield. Sample lysis (whether from whole tissue, cells,
or blood samples) and nucleic acid adsorption are necessary
steps for nucleic acid extraction. The quality and efficiency of
nucleic acid extraction directly influence the research results or
diagnostic output. In many situations, nucleic acid extraction
time accounts for a higher fraction of the total time spent during
the detection process, and hence greatly affects the efficiency
of the entire detection process. Any mistakes during the
extraction process may inhibit the downstream applications
such as polymerase chain reaction (PCR) or alternative
amplification approaches as well as the purity of the end
product 23. This also poses a huge challenge to quality and
consistency. Application of microfluidic systems overcomes this
limitation and improves nucleic acid extraction efficiency
through the precise design, automation, and single system
approach 24-26. Here we highlight nucleic acid extraction
methods that are based on microfluidic systems, and identify
their advantages and limitations.
2.1 Isolation of nucleic acids by Magnetic Beads
Magnetic beads are formed by coating a core of Fe3O4 with an
active group that can be adsorbed by a magnet and then bind
to nucleic acids in a cell or tissue lysate 21, 27, 28. The combination
of beads with nucleic acids is controlled by adjusting the pH or

the salt concentration 29. High flux, automated extraction of
nucleic acids is achieved by applying magnetic beads in synergy
with other bead compositions, such as silicon 30. Their compact
size, ease of handling, and high efficiency when used to isolate
nucleic acids make magnetic beads suitable for microfluidic
platform applications 27, 31-33. The following factors contribute to
the efficiency of magnetic beads for nucleic acid extraction. (1)
The magnetic force on the surface of the magnetic beads. (2)
The strength of the magnetic field. It should be emphasized
here that the force is proportional to the magnetic field gradient
and not the magnetic field intensity. (3) The binding capacity of
the magnetic beads with the nucleic acid. Prior studies have
demonstrated the importance of magnetic beads in isolating
RNA. For example, Shi et al. proposed a Total RNA Extraction
Droplet Array (TREDA) system for RNA purification. The authors
have developed a system that uses hydrophilic spots to hold
stationary droplets and uses magnets to control the movement
of magnetic beads between droplets (Fig. 2A). This approach
can extract total RNA in a low cell concentration medium in less
than 5 minutes and the product can be used readily for
quantitative real-time PCR (qPCR) platforms 34. This approach is,
therefore, highly amenable to simultaneous extraction of
multiple samples and the extraction of trace samples from
complex sources.
Surface tension is an important parameter in the application of
magnetic beads in microfluidic chips since it can achieve the
separation of different extraction components at the
microscopic scale 35-37. Mosley et al. revealed the potential of
magnetic beads to extract nucleic acids from complex samples
using a microfluidic system (Fig. 2B). They leveraged surface
tension to separate reagents and employed an external
magnetic field to control the movement of magnetic beads to
achieve DNA extraction from stool samples. In this study, the
authors used mineral oils with better biocompatibility to
separate different components, and chose the appropriate lysis
buffer (5M Guanidinium hydrochloride, GuHCl) optimized to the
amount of magnetic beads for efficient nucleic acid extraction
38. Shu et al. 39 proposed an Active Droplet-Array (ADA)
approach in which the reagents are pre-stored in water-in-oil
form and the oil phase infiltrates the micro-cells and slits while
the aqueous phase is excluded due to surface tension.
Meanwhile, lysis, washing, elution, and detection are
accomplished by automatically controlling the movement of
beads in the droplet array. The latter system provides the
magnetic beads with automation control and reduces handlingrelated contamination issues.
The magnetic bead method is suitable for automated extraction
and many commercial automatic nucleic acid extractors are
based on this method such as MagNA Pure96 (RocheTM), Smart
LabAssist-32 (TAN BeadTM), BioRobot MDx (QIAGEN), and SPRITE (Beckman). The magnetic bead-based nucleic acids
extraction process is rapid and results in high-efficiency
extraction when integrated with microfluidic platforms. The
advantage of magnetic beads combined with microfluidic
platforms in automated extraction of nucleic acids is likely to
promote the development of molecular diagnostics in the
future. However, the control of magnetic beads is still a difficult
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challenge and requires a complicated control system to achieve
automation. This technical limitation renders most of the
current products to be bulky and costly, which limits its
application in POC and other clinical applications. It is also
important to note that nucleic acid extraction should be
performed in an absolutely closed environment to prevent
exogenous contamination. At present, although certain
measures have been developed to prevent contamination,
some products are still vulnerable to contamination.

microfluidic nucleic acid extraction based on this method
requires relatively complex equipment such as those required
for manufacturing of the chips, which limits the application of
this method.

2.2 Silicon-based method of nucleic acid isolation

Paper, a new branch of microfluidic technology, is an attractive
and inexpensive platform (Lab-on-a-paper) for nucleic acid
extraction due to its inherent advantages such as
biocompatibility, high surface area, and absorptive nature 53-55.
A filter paper consisting of lysis reagent and protein
denaturation reagent can be used to store reagents in a dried
form for long periods without refrigeration 19, 56, 57. Commercial
filter papers have been launched in the market, including
products such as 903® paper and a Fast Technology Analysis
(FTA)® card 58. The pores of filter paper not only affect the
binding of nucleic acids (such as DNA) but also influence the
post-preparation processes such as PCR efficiency and stability.
These are the two major challenges of using paper-based
microfluidic chips for nucleic acid extraction 59. One of the
common methods of nucleic acid extraction by paper-based
microfluidic chips involves the use of lysis buffer and extraction
buffer in the reservoir module 60, 61. Chitosan is used to prevent
the inhibitory effects of guanidine and isopropanol on PCR and
it can be applied in nucleic acid extraction with paper-based
microfluidic chips 62. Gan et al (Fig. 4) developed a chitosanmodified Fusion 5 filter paper by embedding it in a
thermoplastic microchip. This highly efficient approach
leveraged the principle of the entanglement of DNA with fibers
and the electrostatic adsorption of DNA to chitosan polymers 63.
This idea is similar in principle to the approach proposed by
Byrnes et al, who developed a porous chitosan membrane that
could purify and concentrate DNA from complex samples 64. To
extract RNA, Roriguez et al. 65 proposed an alcohol precipitation
method based on a polyethersulfone (PES) filter paper. The
filter paper was used to detect H1N1 from human clinical
nasopharyngeal specimens. The fastest nucleic acid extraction
has been achieved using a filter paper (Whatman No.1). Filter
paper allows rapid extraction and purification of nucleic acids
from plants, animals and microorganisms within 30 seconds at
a very low cost 66. As a result, this technology can be used to
extract DNA and RNA without specialized equipment.
Over the years, researchers in different fields have been using
several methods for nucleic acid extraction from paper
technology. This technology can extract nucleic acids from
samples with different viscosities such as raw viscous samples
67, urine 68, and bacteria solutions 69. Optimization of paperbased microfluidic chips will help increase the efficiency and
decrease the cost of nucleic acid extraction. In addition, several
studies have revealed that nucleic acid amplification methods
(such as PCR, LAMP) can be conducted directly within a paper
membrane 70-72, making the paper method suitable for nucleic
acid extraction. Although the paper-based microfluidic chip has
its unique advantages, it still needs to overcome the challenge

Silica is widely used in DNA extraction because of its stability,
biocompatibility, and easy modification properties, especially in
Solid Phase Extraction (SPE) 40, 41. Being an important sample
pretreatment and enrichment technology, the application of
SPE in microfluidic chips has attracted much attention and is an
effective strategy for integrating nucleic acids in microfluidic
devices 42-44. The target nucleic acid molecule combines with the
silica-based material that is modified on the microfluidic chip in
the presence of high chaotropic salt concentration 45-47. The
bound nucleic acids can be washed with the appropriate
solution, such as diluted ethanol or isopropanol, and then
quickly eluted by a small amount of solvent to extract the target
nucleic acid 48. Different forms of silicon have been utilized in
the microfluidic system for nucleic acid extraction. In 1999,
Christel et al.49 demonstrated that silicon fluidic microchips
could be used for DNA extraction. In this study, thousands of
micropillars with a silica surface were fabricated by deep
reactive ion etching on a silicon wafer, which increased the
internal surface area of the chip. Ramsey’s group 50 applied silica
membranes for the concentration of DNA on the microfluidics
which allowed for DNA fragments to be concentrated up to 2
orders of magnitude. Petralia et al. used silica-coated pillar
arrays on microchips to extract DNA (Fig. 3A) and reported that
elution efficiency strongly depended on the geometrical
dimensions of the pillars and efficiency increased with the
surface/volume ratio 51. Park et al. 48 developed a complete
rotating microfluidic system using silicon beads as a material for
DNA extraction (Fig 3B). The authors applied the geometrical
depth on the chip so that reaction liquid was stored in the chip,
and the precise design of the microfluidic system and rotational
speed control could ensure that each step progressed smoothly.
Based on this method, they integrated DNA extraction and
amplification into a centrifugal chip and detected 50 colony
forming units (CFU) of pathogens within 80 minutes. Gunal et
al. 52 used monodisperse-porous silica microspheres on the
microfluidic system to isolate 14 ng DNA from 10μL of whole
blood lysate, further demonstrating the value of silicon-based
approaches in nucleic acid isolation.
On-chip silicon solid-phase extraction technology not only
reduces the complexity of the analysis and the time required,
but also promotes the integration and miniaturization of
analytical instruments. However, nucleic acid extraction based
on this method produces more waste liquid; therefore, a
suitable waste liquid storage area has to be designed on the
microfluidic chip to prevent or reduce pollution. Moreover,

2.3 Paper-based method of nucleic acid isolation
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in NAAT such as reagent storage, and automation 55, 73. In
addition, paper-based nucleic acid extraction is performed in an
open environment and it is susceptible to contamination during
the extraction process. Therefore, it is likely that a combination
of paper extraction methods with microfluidics will overcome
these challenges and broaden the scope of application for this
cost-effective approach.
2.4 Alternative nucleic acid purification methods based on
microfluidics
In addition to the methods mentioned above, several simple
and efficient nucleic acid extraction methods based on
microfluidic systems have been developed for nucleic acid
detection. These methods play a positive role in the
development of microfluidic systems and increase the efficiency
of nucleic acid extraction using microfluidics platforms.
Appropriate processing and modification of existing materials
could allow extraction of nucleic acids using simple and
common materials, thereby making these approaches more
accessible. Fu et al. used poly-diallyl-dimethylammoniumchloride (PDDA), which has a large amount of positively charged
quaternary ammonium groups, to modify the internal surface
of a capillary making it able to attract negatively charged DNA
or RNA 74. Organic solvents can also be applied to microfluidic
systems for nucleic acid extraction. Morales et al. developed a
dual inlet-dual output serpentine device that allows DNA
isolation in the aqueous phases under stratified flow and
droplet-based flow conditions 75. In a recent study, a novel
microfluidic liquid phase nucleic acid purification chip was
developed by Zhang et al. The chip was designed to selectively
isolate DNA or RNA from low Copy/Single Bacterial Cells in the
range of 5000 down to a single cell in a sample volume of 1 μL
or 125 nL. The on-chip liquid phase nucleic acid purification was
10-fold higher than the conventional column-based solid phase
nucleic acid extraction methods with the added advantage of
small volume handling capacity 76.
Application of microelectronic components to a microfluidic
system has also been found to be effective in nucleic acid
extraction. Marshall et al. proposed the use of integrated
heaters in combination with isotachophoresis to lyse the
sample and isolate nucleic acids 77. The authors used this system
to process nucleic acids from clinically-derived blood samples.
Han et al. invented a Self-powered switch-controlled system
(SSNES) which has two disposable syringes and a switchgear
made of polymethyl methacrylate (PMMA) blocks and an O-ring
for the nucleic acid extraction. In this system, the authors use a
dimethyl adipimidate (DMA)-based extraction method with the
microfluidic system 78. Yoon et al. 79 also reported a DMA chip
for RNA extraction from different cell lines with rapid processing
time and high product purity (Fig. 5A).
Different chemicals that bind nucleic acids, can be applied to
microfluidic systems for efficient nucleic acid extraction. Jin et
al. incorporated dimethyl pimelimidate (DMP) into the
microfluidic system which led to efficient extraction of nucleic

acids (DNA and RNA) from various samples such as mammalian
cells, bacterial cells, and viruses from human disease (Fig. 5B).
The DMP captures the nucleic acid and the system does not
need instruments or electricity 20. Since plasma is an important
sample source for clinical testing, Liu et al. proposed a simple
and highly efficient plasma separator that does not need
centrifugation. Compared with other POC methods, this
separator has higher DNA recovery efficiency, reaching up to
84.5% 80. Adjusting the properties of the material and the
charge of the nucleic acid allows for a greater range of isolation
methods to be integrated with microfluidic platforms. Although
the methods mentioned above apply different principles for
nucleic acid extraction using microfluidic systems with unique
advantages, their efficiency, affordability, security, and
simplicity need to be further optimized for broader application
and accessibility. A key area that need to be improved is the
integration of nucleic acid extraction with downstream
reactions. Several integration approaches have been identified
to date that can contribute to POC and increased treatment
efficiency 81-84, but opportunities remain to build on these
technologies. Regardless of the isolation method utilized,
certain measures should be taken to prevent nucleic acid
contamination and ensure accuracy of the results and quality of
the product.
3. Nucleic acid amplification using microfluidics approaches
Microfluidics-based approaches provide an ideal platform for
nucleic acid amplification and rely mainly on fast prototyping by
soft lithography in Polydimethylsiloxane (PDMS) or glass
etching 85, 86. Although PDMS has been applied in many studies,
the issue of evaporation limits its practical application due to
gas permeability. In addition to this, injection molding87, 88,
thermal bonding and hot embossing89, 90 along with changes in
solvent use 91-93 are important alternatives which can improve
nucleic acid amplification on a microfluidics system. Nucleic acid
amplification on chips also confers the advantages of
amplification speed, detection limit, sample demand, and
detection accuracy 42, 94. In recent years, many kinds of nucleic
acid amplification approaches such as PCR and isothermal
amplification have been performed on the microfluidic system,
with the achievement of fast and accurate detection. This
section will summarize several promising techniques which
have been used on microfluidic systems.
3.1 Digital PCR (dPCR) amplification of nucleic acids
qPCR technology is used to quantify nucleic acids and is the gold
standard for the diagnosis of infectious diseases 95-97. However,
it is a relative quantification technique that relies on a standard
curve or reference gene assessment to determine the amount
of target nucleic acid. For low copy number target DNA, issues
such as primer efficiency and differences in template
concentrations can markedly affect the detection sensitivity
and accuracy at the end-stage 18, 19, 98, 99. dPCR is a third
generation PCR technology which can provide a direct count of

4 | J. Name., 2019, 00, 1-3

This journal is © The Royal Society of Chemistry 20xx

Please do not adjust margins

Page 5 of 21

Lab
onadjust
a Chipmargins
Please do
not

Journal Name

ARTICLE

target molecules without relying on any calibrators or external
standards to determine the absolute number of molecules as
low as a single copy 66. The concept behind digital PCR was first
proposed by Sykes et al in 1992 100. Although this method was
not referred to as "digital PCR" at the time, the basic
experimental procedure for digital PCR was established.
Moreover, the fundamental principle of digital PCR detection
provided an all-or-none for the assay 101. In 1999, Vogelstein
and Kinzler performed dPCR reactions using microplates for the
first time, which allowed for a high throughput strategy 102. This
approach allows for large-scale multiple dilution and liquid
separation until the number of molecules to be detected does
not exceed 1 (0 or 1) in each subdivided sample. All subdivided
samples were subjected to PCR amplification under the same
conditions, and the target molecules are amplified to generate
a very strong fluorescence source. The number of samples and
total number of microwells are counted and the Poisson
distribution is used to predict the initial concentration of the
target sequence 103, 104. dPCR can be further divided into droplet
digital PCR (ddPCR) and integrated flow circuit (IFC) chip dPCR.
Studies have demonstrated that ddPCR and IFC dPCR are more
robust than standard qPCR approaches for detecting trace
samples 101, 105, 106 and have been applied in gene mutation
analysis 47, 107, prenatal diagnosis of chromosome abnormality
46, 108, DNA copy number determination 50, 107, pathogen
detection 78, 109, transgenic detection 55, 68, among other
applications. Modifications to dPCR chip have been developed
in recent years that have advanced the application of this
innovative approach for detection and quantification of nucleic
acids. Microfluidic technology in combination with dPCR offers
greater throughput, high sensitivity, and improved accuracy
over more traditional PCR-based methods.
Researchers have broken through many technical bottlenecks
with the development of Micro-Electro-Mechanical System
(MEMS) and microfluidic technology 73. Hansen’s group
developed an ultra-high density megapixel digital PCR chip with
1 million cells. The chip can have a density of up to 440,000
reactors per square centimeter and a reaction chamber size of
20 μm×20 μm×25 μm, which offers a dynamic range of 107 65.
Shen et al. 110 established a slipchip consisting of two glass
sheets, one etched with a reaction cell and the other linked to a
channel. When the two lamellae are combined with the
channel, a continuous flow path is formed, and the reaction
reagent can enter the reaction chamber from the inlet to reach
the outlet. When the two chips slide, the channels and the
ridges are misaligned and the flow path is cut off. In recent
years, our group developed an integrated temporary negative
pressure-assisted microfluidic chip to combine DNA isolation
and digital PCR detection in one chip. This research laid the
foundation for the connection between different functional
areas 111. Our team has developed a series of self-priming,
liquid-divided, integrated flow path chips. An integrated onchip, valve-free and power-free microfluidic dPCR device has
been developed based on a novel self-priming
compartmentalization for the first time 112. In 2017, our team
reported a dPCR chip with a scalable branch network structure

(Fig. 6). The chip is a fully-encapsulated dPCR chip that has no
waste or cross-contamination from the external environment.
In addition, a negative pressure liquid separation method has
been adopted in which the uniform dispersion of the sample
can be accomplished without the aid of an external device. This
method is more flexible and is suitable for rapid isolation113.
Ning et al. 114 proposed a digital PCR chip with zero-water-loss.
In this low-cost chip, the authors integrated a void in the space
beneath the microwells, which provided power and water
storage during the isolation procedure.
In recent years, several techniques and instruments based on
digital drop PCR (ddPCR) have been developed. Compared to
microarray chips, the processing of ddPCR chips is simpler and
the number of droplets is more flexible than in previous
iterations of the technology 72, 115. Chen et al. reported a
capillary-based droplet dPCR chip, which integrates droplet
generation, PCR reaction, and flow detection in a single system.
This approach avoids the fusion of droplets in the reaction
chamber and sample loss caused by transfer between
instruments 116. An ideal ddPCR assay should be easy and fast to
operate in most laboratories. Huang et al. developed an off-chip
monodispersion droplet generation method that can efficiently
produce results without an emulsion step using a highly precise
micro-channel array and a bench-top centrifuge machine. The
results were robust and the cost of dPCR was reduced,
supporting the idea that dPCR could be adopted in standard
molecular laboratories 117.
Compared to traditional quantitative PCR techniques, dPCR
achieves absolute quantification by measuring the copy number
of a specific gene. However, dPCR cannot be used, at this time,
to perform large-scale gene sequencing and can only be used
for quantitative detection of specific known genes. Multiplex
PCR detection is likely to be an attractive development direction
for this technology and will promote the application of dPCR in
mutation analysis 96 and genotyping 105, for example. In
combination with different fluorescent probes or different
intensities of fluorescence, dPCR can be applied in multiple
detection systems 105, 118-120. Didelot et al. 121 used a multiplex
picoliter droplet–based digital PCR method to detect human
genomic DNA samples of 4 lengths (78, 159, 197, and 550 bp)
and the results were consistent with the sequencing data run in
parallel. Zhong et al. 122 reported a novel and easy method
which is based on the singular nature of amplifications at
terminal dilution for multiplexing dPCR in picolitre droplets. The
authors theoretically performed 10 multiple detections by this
approach. To achieve these results, they used 5 multiple
detection assays for spinal muscular atrophy with just two
fluorophores.
In addition, it is worth mentioning that the detection method of
digital PCR results mainly relies on the quality and intensity of
the fluorescent signals (fluorescent dyes and probes) which can
increase the cost of digital PCR and limit its application in POC
diagnosis. Therefore, it is necessary to develop low cost
detection devices or other signal readout methods to promote
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its wider application. The technology of dPCR is rapidly growing
and its performance in different fields is expected to eventually
outperform qPCR. The Minimum Information for Publication of
Quantitative Real-Time PCR Experiments (MIQE) Guidelines for
dPCR were proposed by Huggett et al 123. Similar to the MIQE
for qPCR 124, the MIQE for dPCR will help to standardize
experimental protocols, maximize efficient utilization of
resources, and enhance the impact of this promising new
technology.

comparable sensitivity and detection efficiency to qPCR and
dPCR129. In 2018, a study by Chiu improved on this digital LAMP
self-digitization (SD) chip 133 and proposed a new SD chip for
digital LAMP to detect HPV-18 gene with higher efficiency 134.
In many cases, only the presence or absence of target is
required in POC. Therefore, the application of LAMP in POC
does not necessarily require absolute quantification. Yuan et al.
developed a disc chip using colorimetric LAMP for the detection
of peanut, sesame and soybean allergens. The authors found
that the detection limit was as low as 0.4 ng/μL130. An
automated approach using the lab-on-a-disc and a miniaturized
3.2 Isothermal Quantification of nucleic acids
rotary instrument equipped with three heating blocks was
Since qPCR requires a thermocycler and a 2-3 hour amplification developed by Oh et al 135. The authors demonstrated that a milk
time, it is not suitable for POC in all cases. Given the sample contaminated with foodborne pathogens could be
developments of nucleic acid amplification technology in recent automatically run on the centrifugal disc by LAMP with a
years, nucleic acid isothermal amplification technology has detection level as low as 10 bacteria within 65 minutes. A LAMPbeen increasingly applied in POC systems. The nucleic acid based approach using on-capillary array technology was
isothermal amplification technology does not require different developed by Ning et al 136. This microarray performs
temperature cycles to generate new product from the nucleic hydrophobic processing on capillaries and immobilizes primers
acid template. It does not depend on sophisticated equipment into capillaries via chitosan to process LAMP with a detection
and has shown good application prospects in POC. Among the sensitivity as low as 50 copies/capillary. Trinh et al. 137 have
isothermal amplification techniques, Loop-mediated isothermal designed a multiplex LAMP plastic microdevice chip that is ecoamplification (LAMP) has relatively wider application than other friendly, and can rapidly detect four pathogens within a
technologies. Recombinase Polymerase Amplification (RPA) is a concentration range of 0.12-0.13 ng/μL.
nucleic acid detection technology that has also shown broad Since the amplification product of LAMP contains large amounts
application prospects 125-127. Both approaches offer alternatives of pyrophosphate in addition to the double-stranded nucleic
for nucleic acid amplification that may be amenable for use in acid, the signal readout of LAMP is more flexible than that of
POC.
traditional PCR. In recent years, fluorescence signals138, 139,
electrochemical signals140, 141, and visual detection142, 143
3.2.1 LAMP-based quantification of nucleic acids
readout methods have been applied successfully to microfluidic
The principle of Loop-mediated isothermal amplification (LAMP) platforms to promote the application of LAMP in pathogen
is that at a temperature of 65°C, DNA is synthesized constantly detection and clinical diagnosis. The microfluidic-based LAMP is
and self-recycling is facilitated using 4 primers (2 external effective in achieving rapid results and miniaturized detection.
primers and 2 internal primers) and a DNA polymerase (Bst DNA However, due to the LAMP reaction conditions, further efforts
polymerase) that lacks a 3’ to 5’ exonuclease proofreading are required to improve detection specificity, primer design,
capability 128. Compared with dPCR, dLAMP has a shorter and temperature control for optimization of LAMP. Moreover,
reaction time and better anti-inhibitory capacity, which points chip designs that implement multiple target detection on one
to the rapidity and reliability of the method for use in POC 129, chip would be of significant value and need to be developed.
130. To meet the needs of on-site testing, it is necessary to preembed reaction reagents into the chip. Ma et al. developed a
3.2.2 RPA-based quantification of nucleic acids
self-driven microfluidic method by creating hydrophilic PDMS
surfaces that allow for digital LAMP. The surfaces remain stable RPA requires a recombinase capable of binding single-stranded
for 6 months after dry storage without major loss of efficiency nucleic acids (oligonucleotide primers), a single-stranded DNA
131. The detection process takes 30 minutes and the technique
binding protein (SSB), and a strand displacement DNA
can identify as few as 11 copies of a specific target gene in the polymerase which is active at room temperature, and an
genome. dLAMP integrates well with different droplet optimal temperature at 37℃ 119. The first step in this process is
generation methods. A Droplet Digital Detection (IC 3D) system the formation of a complex between the recombinase and the
was proposed by Zhang et al 132. The system generates droplets, primer. This complex binds to complementary DNA of the
‘microreactors’, that are incubated at an isothermal homologous sequence in the double-stranded DNA. Once the
temperature for several minutes to generate a fluorescence primers are bound to the homologous sequences, a chain
signal which indicates the formation of the product. Hu et al. exchange reaction occurs to initiate DNA synthesis and
invented a method to rapidly and continuously generate a large exponentially amplify the target region on the template. The
number of microliter droplets up to nanoliter volume and replaced DNA strand binds to SSB to prevent further
applied it in digital LAMP for rapid quantitative detection of H5 substitution. In this system, a synthetic event is initiated by two
Subtype Avian Influenza Virus. This method utilizes the opposing primers and the whole process is completed within 10
interfacial tension between the oil and air. As a result, the minutes. This approach offers a faster amplification method
authors were able to demonstrate that dLAMP had a
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than PCR or LAMP．Moreover, there is no evaporation problem
due to the relatively low reaction temperature 126, 144.
In recent years, several researchers have adopted this approach
to incorporate microfluidics in order to improve on the rapidity
and accuracy of RPA 125, 127, 145. Li et al. designed a Picoliter Well
Array Chip for dRPA which could function at 39℃ in 20 minutes
26. The chip has 27,000 picoliter wells (314 pL) and crosscontamination between microwells is avoided through
silanization modification by methoxy-PEG-silane. Schuler et al.
25 performed a digital droplet RPA by the centrifugal step
emulsification method in order to detect Listeria
monocytogenes DNA. Shen et al. 23 developed a digital RPA Slip
Chip, which can be used for absolute quantification of target
nucleic acid molecules. Multiple RPA-based detections can also
be implemented on a microfluidic platform as demonstrated
recently by Song et al146. The authors designed a high-level
multiplexing microfluidics chip dubbed rapid amplification
(RAMP), which consists of a first-stage RPA and second-stage
LAMP. The approach was rapid, requiring only 40 minutes, and
provided high sensitivity and specificity for target detection.
Kersting et al. developed an on-chip multiplex RPA approach
which is performed in a programmable hybridization chamber
and can detect 10 CFU of methicillin-resistant Staphylococcus
aureus and Salmonella enterica and 100 CFU for Neisseria
gonorrhoeae in <20 minutes147. Choi et al. described a direct
RPA strategy on a disc chip. This strategy can simultaneously
detect Salmonella enterica, Escherichia coli O157:H7, and Vibrio
parahaemolyticus in 30 minutes from milk samples without
DNA extraction 94. Chen et al. 24 also developed a disc RPA chip
which can simultaneously detect five distinct pathogens from
urine samples within 40 minutes. Because RPA has a unique
amplification principle and does not require a cycle
temperature similar to PCR, the RPA can be combined with
other technologies to achieve rapid detection on microfluidics.
A
new
technique
for
isothermal
solid-state
amplification/detection (ISAD) was proposed to rapidly detect
single point mutations in cancer 148. This is a label-free, realtime detection technique that combines RPA with a solid-phase
amplification based on silicon microrings. In this study, ISAD was
used to detect single mutations in the Harvey RAS gene, and this
approach yielded an amplification product efficiency 100-times
greater than that of RPA and conventional PCR methods, alone,
in terms of sensitivity. To detect RPA amplification products,
real-time fluorescent detection94, 149 or lateral flow detection150,
151 are mainly used on the microfluidics system. Additional
product detection methods should be developed to promote
the application of RPA. In recent years, RPA technology based
on microfluidics has witnessed rapid advancements. To increase
accessibility of this technique, the production cost of the chip
and the reaction cost of the RPA should be reduced. Moreover,
due to the high sensitivity of RPA, one of the limitations for its
use is related to non-specific product amplification and
contamination. These latter concerns should be considered
with regard to the use of RPA in combination with microfluidic
platforms. Further optimization of primers and probe

sequences for different genes will increase the feasibility of
using RPA-based microfluidic approaches in POC systems.

4. INEAD system and clinical application
4.1 INEAD systems
The integration of sample preparation and amplification on a
microfluidics chip system can prevent contamination, reduce
sample loss, and reduce detection time. Thus, the INEAD system
has the potential to produce more accurate and robust
detection results with reduced time cost. Over the years,
various strategies have been tested to optimize integration and
automation of the INEAD system and this section introduces
some approaches for implementing the INEAD system.
The centrifugal microfluidic chip could pre-embed the reagents
required for the extraction and amplification processes on a CDshaped chip. The centrifugal force serves as the driving force for
the liquid flow 41, 152, 153. Jung et al. 154 developed a microfluidic
chip integrated with RNA extraction and RT-LAMP to extract
influenza virus RNA. The chip contains four reservoirs: a viral
RNA sample pool, a wash solution pool, an eluent pool, and an
RT-LAMP reagent pool. It also contains two chambers: the
waste reservoir and the RT-LAMP reaction chamber. By
controlling the rotational speed of the chip, viral RNA samples,
washings, eluents, and RT-LAMP reagents are sequentially
passed through the microbeads by different centrifugal forces
to control adsorption and subsequent washing and elution of
nucleic acid product. Loo et al. 152 introduced a centrifugal chip
integrating DNA extraction and LAMP that can be used to
quantify the number of target bacteria by fluorescence intensity
from only a small amount of body fluid sample (Fig.7B). Zhang
et al. 155 reported a disc chip in which the nucleic acid
purification was integrated with the LAMP approach. The chip
can be used to detect six kinds of pathogens simultaneously in
an electricity-free manner. This latter feature demonstrates
that this approach may have great potential for application in
POC systems. As a simple way to achieve integration, in recent
years, many studies have been based on centrifugal force 24, 156158 and commercial applications have been implemented that
point to this technique as having increasingly broad application.
Paper microfluidics is another ideal platform for integration
which could process the fluid in the reaction by introducing
buffers, samples and reagents. Connelly et al. 53 developed an
integrated system containing sample preparation and LAMP
(Fig. 7A). The paper-based chip has a multi-layered structure
and slides in and out of the paper chip to introduce a sample
and a reaction reagent. Finally, LAMP's endpoint detection is
simplified through use of a handheld UV power and camera.
While this will reduce the automation aspect of this particular
approach, it will allow for a low tech option in cases where POC
sites have limited technical resources. Tang et al. also designed
an integrated paper-based system in which the authors used a
sponge-based reservoir and a paper-based valve for nucleic acid
extraction. The subsequent isothermal reaction was achieved
with micro-heated components and pre-embedded reagents.
The system could detect Salmonella typhimurium in food
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samples within 1 h with a detection limit as low as 10-2~10-3
bacteria 60.
Capillaries are also an effective tool for integration in many
nucleic acid purification and amplification approaches. Liu et al.
159 developed an excellent approach for integrating capillaryarray microsystems that includes a heating block, a
multichannel syringe pump, a bidirectional magnetic force
controller, and a fluorescence detection module (Fig. 7C). In this
system, DNA extraction and LAMP products detection were in
the capillary-array with the capacity to process 10 samples
simultaneously. Fu et al. also reported an integrated capillary
system which could allow on-site qPCR 74. In this method,
nucleic acid extraction was achieved through a PDDA modified
capillary followed by temperature control of the PCR through
water circulation pumps. This system achieved the steps
(including extraction, amplification, and detection) within 40
minutes.
Some industries have launched fully automated nucleic acid
diagnostic products such as GeneXpert®, Filmarray ®, and Atlas
Genetics io®.GeneXpert is a fully automated molecular
diagnostics platform developed by CepheidTM. The GeneXpert
reduces user handling of samples by integrating sample
preparation steps with PCR amplification and real-time
fluorescence detection in the same cartridge. This is a closed
system that relies on valve actuation and hydraulic control. The
PCR process is fully automated, with simple operation and fast
results. The Cartridge of GeneXpert is used for quantitative
detection of multiple samples. Since it involves nucleic acid
extraction, amplification, and monitoring, the cartridge
structure is complex and costly. Filmarray is a fully automated
molecular diagnostics platform based on microfluidic
technology that provides qualitative target detection and is
developed by BioFireTM. This approach utilizes a test strip that
contains all reagents needed for nucleic acid extraction and
amplification. The product uses multiplex PCR analysis
technology to perform the detection of up to 24 targets at a
time on the same sample within an hour and is ideally suited for
early rapid screening of multiple infectious diseases. Atlas
Genetics is a microfluidic-based POC product developed by
Atlas GeneticsTM. Considering that electrochemical detection is
employed in this product, no complicated optics are needed in
the instrument, and the instrument could be miniaturized for
portability making it ideal for POC sites. In 2016, Bohui
CompanyTM successfully developed a fully automatic
genotyping detection chip for Human Papilloma Virus (HPV)
that integrates sample processing, nucleic acid amplification
and multiple interpretations. One major advantage for this
technology is the rapidity since only 2 minutes are required to
complete sample processing and detection. The detection
requires a chip controller only, which contributes to the
automation of the whole process from nucleic acid extraction,
PCR amplification, reverse hybridization to results
interpretation. Another advantage of this approach is that the
entire experiment can be conducted in a sealed chip, which not
only avoids DNA contamination, but also eliminates human
error introduced by manual operation.

The integrated microfluidic POC system has been flourishing as
a means to conduct fast, accurate nucleic acid detection. These
systems are often pre-packaged, with a predetermined reagent
solution in the chip or with the reagent in the reservoir. Indeed,
nucleic acid extraction coupled with “in situ PCR” has been
found to have great application in INEAD 63. However, there are
not many researches on digital nucleic acid detection integrated
with sample preparation to achieve “sample-in-digital-answer
out (SIDAO)”. Based on the air permeability of PDMS, a
microfluidic chip which used the negative pressure provided by
a syringe to achieve sample injection and enable digital PCR
reactions was developed. The systems were successful in
isolating and amplifying nucleic acid from a tissue source 111.
This approach is convenient and rapid, cost-effective, accurate,
and suitable for use in a standard molecular laboratory. Yang et
al 160 also reported a system that integrated the DNA extraction
and digital RPA (Fig 7D).The system had an automated module
to allow liquid transfer and the reaction buffer was injected into
the digital RPA chip through the mechanical pressure. Using this
system, they successfully performed absolute quantification of
a Mycobacterium tuberculosis gene from saliva and serum.
4.2 Clinical application of the INEAD system
As medical care advances, the demand for cost-effective, rapid
and accurate nucleic acid detection has pushed technological
advances that promote the application of INEAD system in
clinical practice. Many commercial INEAD systems have been
clinically applied in point-of-care testing (POCT) of tuberculosis
161, 162, HIV163, Methicillin-resistant Staphylococcus aureus164,
and Chlamydia trachomatis165. The INEAD approaches used
were found to give accurate results in a short time frame, which
helped to promote medical development and support in remote
areas. Indeed, some of the approaches have been endorsed by
the World Health Organization (WHO) 166. In a recent study, Xin
et al 156 test for the presence of the rotavirus A from 48 clinical
stool samples using the INEAD system and found that the
sensitivity and specificity were both 100%. Wang et al 167
detected the S. pneumoniae and M. pneumoniae from 63
clinical specimens (oropharyngeal swabs and bronchoalveolar
lavage fluid), which further supported the value of using INEAD
systems for the analysis of clinical specimens. The clinical
application value of the INEAD system was also demonstrated
by Choi et al., in the positive test of 16 HBV- clinical samples168.
While quite a bit of recent progress has been made, it is
important to recognize the value of further research involving
INEAD-based approaches for accurate, rapid detection of virus,
pathogen, or immunogen in patient samples.
5. Summary and Conclusions
In the current review, the history and development of the
microfluidics field was captured to provide an assessment of
past and current techniques in terms of accuracy, reliability,
cost and speed, particularly in the context of POC. Further, this
study offered the current perspective on the state of this field
in terms of areas for future growth and technological
advancement. This work compared methods for nucleic acid
extraction on microfluidic systems, methods for nucleic acid
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amplification, and integrated microfluidic chips for sample
preparation combined with nucleic acid amplification.
In terms of sample preparation, this study offered insight into
the different nucleic acid extraction methods based on
magnetic beads, silicon-based materials, and paper-based
materials, in the context of their use with microfluidics. The
magnetic beads method is characterized by controllability and
high flux along with simple and fast procedures. Silicon material
is especially suitable for SPE. Paper-based nucleic acid
extraction is characterized by low cost and rapid completion
time, offering several advantages over other methodologies.
Meanwhile, there are many different ways to achieve nucleic
acid extraction, many of which can be integrated with
microfluidics for optimal outcome. The choice of nucleic acid
extraction method determines the methods of integration with
downstream nucleic acid amplification and the speed of
detection for the entire process, which are crucial parts of
nucleic acid detection.
For nucleic acid amplification methods on microfluidic systems,
this study introduced dPCR, LAMP and RPA methods which are
currently widely used and have high potential for POC
application. dPCR, as the current mainstream nucleic acid
amplification method, is suitable for microfluidic systems due to
its technical maturity given that 20 years have passed since it
was first proposed. The application of this technology to
microfluidic systems requires less reaction completion time and
results in higher sensitivity. LAMP-based instruments are
simpler, cheaper, and consume less energy during the heating
steps. However, RPA is the only current nucleic acid
amplification technology that can rapidly react at room
temperature. In the microfluidic system, the analysis
performance, throughput, detection accuracy and dynamic
range of the digital nucleic acid amplification should be further
explored.
6. Future Outlook
The microfluidic chip revolutionized and integrated the process
of nucleic acid extraction, amplification, and detection but
many challenges are yet to be resolved. For sample preparation,
recent technology allows for the extraction of nucleic acids on
the microfluidic system from simple samples but cannot readily
handle more complex samples such as bone, animal and plant
tissue. Therefore, handling complex samples on microfluidic
systems is still an urgent problem. Moreover, the complete
encapsulation of nucleic acid extraction will be a particularly
effective advancement to prevent nucleic acid contamination
during processing. In addition, the challenge of optimal
integration of the sample preparation with digital nucleic acid
amplification to achieve SIDAO needs further exploration.
Further development of INEAD systems using the microfluidic
chip will help us to realize more accessible “sample-in-answerout” to improve rapid and accurate test results in POC. However,
the velocity, reliability, accuracy and cost of the integrated
systems will continue to be key hurdles to progress and broad
use of these technologies in POC.
Moving forward, for better service in POC and clinical
application, any commercialized integrated system should also
be miniaturized and affordable. Although there are presently
many products, the cost is high and presents a barrier for broad

accessibility to some economically disadvantaged and rural
areas. To make nucleic acid extraction-microfluidics an integral
part of rural or emergency care, POC will require a significant
improvement in costs associated with the sample prep and
technology. In future, the application of INEAD systems for POC
must have the characteristics of automation, low cost,
versatility and miniaturization. It would also be important to
have a visualized data output module and information
transmission module to allow for improved communication of
results between POC and potential clinical partners at more
metropolitan hubs. Therefore, future POC personnel would not
need specialized, operational training beyond careful sample
collection and basic instrument handling. In addition, for most
rural and remote areas, lack of resources and economical
constraints remain limiting factors. In the future, the application
of the INEAD system to mobile detection vehicles will enable
them to serve more people in the medical and food safety fields,
which will promote the application of POC systems. This puts
higher requirements on the stability, operability, and energy
requirements for any system developed. In many medical fields,
accurate test results are required and SIDAO is an ideal testing
process leading to improved sample preparation and nucleic
acid detection technologies. It is our hope that this review will
encourage further dialogue and exploration towards the
development of microfluidic systems for NAAT integration. It is
anticipated that future research will provide further integrative
solutions for improving POC and establishing broader
accessibility for microfluidics-based technology across clinical
applications.
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Figure 1 Conceptual integration of nucleic acid isolation, amplification and the microfluidics
platform. Improved technologies that promote efficient and clean nucleic acid extraction will
improve the quality and time cost associated with nucleic acid amplification. Together, these
approaches applied to the flexibility associated with the microfluidics platform can increase the
sensitivity, improve the accuracy, reduce time to results, minimize required technical training, and
improve the development of POC. The end goal is increased treatment efficiency and improved care.
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Figure 2 Magnetic beads-based microfluidic nucleic acid extraction chip. (A) Overview of the TREDA
system (Shi et al., 2015) (a) schematic of the TREDA chip where (b) controls the dispersion,
aggregation, and movement of magnetic beads. Adapted from Ref. 34 with permission from the
Royal Society of Chemistry. (B) Schematic of the DNA extraction process showing (Mosley et al.,
2016) (a) Sample loading and lysis. (b) Mixing of superparamagnetic particles (PMPs) to combine
with DNA. During the process, the magnet can control the movement of the magnetic beads, so the
magnetic beads are in an aggregate state. This process can be accelerated by controlling the
movement of the magnetic beads. (c) Transfer of PMPs through the immiscible phase for washing,
(d) elution of DNA from the PMPs and collection of the nucleic acid for off-chip analysis is shown.
Adapted from Ref. 38 with permission from the Royal Society of Chemistry.
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Figure 3 Silica pillar-based nucleic acid extraction method. (A) Silica-coated pillar arrays on
microchips for DNA extraction (Petralia et al., 2017). The chip is composed of a 6-layer structure and
the size of silicon pillars array is 5 × 1.8 mm2. Adapted from Ref. 51 with permission from the Royal
Society of Chemistry. (B) Silicon bead-silicon beads nucleic acid extraction method. Schematic
illustration of the integrated rotary microdevice for the DNA extraction, the Loop-mediated
isothermal amplification (LAMP) reaction, and the lateral flow strip detection are shown (Park et al.,
2017). Nucleic acid extraction is based on the Silica microbead-bed channel, which serves as a solid
phase matrix. DNA extraction is achieved by controlling different speeds and the extraction efficiency
can be up to 80% in the microdevice. Adapted from Ref. 48 with permission from Elsevier.
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Figure 4 Chitosan-modified Fusion 5 filter paper and DNA capture mechanism (Gan et al., 2017).
(A) 3-mm-diameter discs of chitosan-modified Fusion 5 filter paper. Schematic and scanning
electron microscope image of the fiber matrix coated with chitosan polymers. (B) Schematic of
the DNA capture mechanism. At a pH around 5, DNA molecules are “actively” adsorbed onto the
chitosan-modified fibers. Once DNA is on the fibers, the physical entanglement of the long-chain
molecules with the fiber matrix can also assist the capture. At a pH of 9, although DNA is not
“actively” absorbed onto the fiber, DNA molecules remain bound due to the physical trapping of
these long-chain DNA molecules within the fiber matrix against washing and elution. Adapted
from Ref. 63 with permission from ACS Publications.
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Figure 5 Schematic of DMA chip and DMP chip for nucleic acid extraction. (A) DMA chip for
RNA isolation. a:Cell lysis. Different components including DNA, RNA and protein are released.
b:on-chip RNA isolation. RNA is bound and eluted by controlling pH. Adapted from Ref. 79 with
permission from the Elsevier. (B) DMP chip for DNA and RNA isolation. (a) Chemical structure
of DMP and schematic drawing for assembling of a plastic type microfluidic cartridge with a 3D
disposable chip. (b) schematic and photograph workflows for the DMP system for RNA (b) and
DNA (c) extraction. Adapted from Ref. 20 with permission from ACS Publications.
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Figure 6 Schematic drawing of the fractal branching microchannel net chip (Zhu et al., 2017). (A)
Schematic diagram of the chip that has 4096 microwells for dPCR reaction. (B) Diagram of the details of
the chip design. (C) Photograph of the chip. (D) The scalability of the chip with 16384 microwells in each
reaction panel. (E) The principle and operation procedure of the microfluidic device: (a) the chip is
degassed in a vacuum pump and then adhesive tape is attached to seal the top surface of the chip after
the degassing step; (b) the adhesive tape is punctured, and the reagent can be dispensed into the inlet,
while the degassing-drive flow primes the sample into the microwells quickly; (c) the oil is then dispensed
into the inlet, and the oil phase is self-primed into the channels; (d) all the sample solutions are partitioned
into each microwell by the oil, and no sample is wasted. Finally, the chip is sealed using a coverslip to run
PCR amplification. Adapted from Ref. 113 with permission from the Royal Society of Chemistry.
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Figure 7 Technical variance for the INEAD and SIDAO systems. (A) The paper-based INEAD system (Connelly et al., 2015) is
shown for comparison with the (B) centrifugal microfluidic that integrates the nucleic acid extraction with LAMP (Loo et al.,
2016) and (C) the capillary-based INEAD system (Liu et al., 2013). “A” has the advantage of low cost while “B” and “C” can be
automated. Despite the different integration options of the microfluidic chip, the systems can be simple and fast to achieve
“sample-in-answer-out”. (D) The magnetic bead-based system combines nucleic acid extraction with a digital Recombinase
Polymerase Amplification (RPA) chip (Yang et al., 2018). “D” can automatically achieve “sample-in-digital-answer-out”. Figure
A and C are adapted from Ref. 53 and Ref.159 with permission from ACS Publications, Figure B is adapted from Ref. 152 with
permission from Elsevier, and Figure D is adapted from Ref. 160 with permission from Springer.
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Integrated microfluidic systems with sample preparation and nucleic acid amplification can
increased treatment efficiency and improved care.

